A leading research institution located in Leuven, Belgium and Batavia Biosciences announced their partnership on the development of a vector-based COVID-19 vaccine candidate.
The virology team at the KU Leuven Rega Institute for Medical Research, which was founded in 1954, is headed by Prof. Dr. Johan Neyts, stated in a press release they ‘have developed a SARS-CoV-2 vaccine candidate consisting of an attenuated vector carrying the SARS-CoV-2 spike immunogen.’
Researchers Launch COVID-19 Vaccine Study Based on Yellow Fever
SARS-CoV-2 Seroprevalence Low in U.S. From July to Sept. 2020
Jurisdiction-level seroprevalence varied from less than 1 percent to 23 percent across four collection periods
CDC Director Warns of Dire Winter Ahead for COVID-19 Hospitalizations, Deaths
Redfield says that the coming winter months are going to be ‘the most difficult time in the public health history of this nation’
Mental Health Symptoms Common for Perinatal Women During COVID-19
Women with preexisting mental health diagnoses more likely to have mental health symptoms during pandemic
Everyone Who Gets COVID-19 Vaccine Will Receive Vaccination Card
Wallet-sized card will document what dose has been given and when next dose is due
Teens Still Able to Access E-Cigarettes During COVID-19 Pandemic
Some report changing their point-of-purchase to access products during the pandemic